Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01431612Phase 2Completed
Phase 2, randomised trial of esmolol and phenylephrine in ovarian cyst (3 arms), sponsored by Södertälje sjukhus. Primary endpoint: Urinary excretion at 3 hours. Started Nov 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01431612.